Seoul, South Korea

Si Young Song

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2015-2018

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Si Young Song: Pioneering Cancer Treatment

Introduction

Si Young Song, an innovative inventor based in Seoul, South Korea, has made significant strides in the field of cancer research. With two registered patents to his name, his work focuses on identifying effective treatment agents for pancreatic cancer, a disease known for its aggressive nature and challenging prognosis.

Latest Patents

One of Si Young Song's notable patents is the "Method for screening for a cancer treatment agent using the interaction between PAUF and a binding partner thereof." This inventive method utilizes pancreatic adenocarcinoma upregulated factor (PAUF) alongside binding partners like GLRX3, SNAPIN, or UBL4A. By examining whether a test material inhibits the binding of PAUF to these partners, the screening method can determine its potential as a cancer treatment agent. Additionally, this invention leads to a pharmaceutical composition aimed at inhibiting PAUF signaling, offering a promising pathway to treat various types of cancer, especially pancreatic cancer.

His second significant patent focuses on a "Pancreatic cancer biomarker using the characteristics of pancreatic cancer stem cells, and its use." This invention introduces a unique molecular marker for pancreatic cancer stem cells, enabling early detection of pancreatic cancer. The developed marker can significantly enhance diagnostic accuracy and prognosis analysis for patients afflicted with pancreatic cancer.

Career Highlights

Si Young Song is currently affiliated with the Industry-Academic Cooperation Foundation at Yonsei University. His research endeavors reflect his commitment to advancing cancer treatment and diagnostics, showcasing his profound impact on medical research and innovation.

Collaborations

Throughout his career, Si Young Song has collaborated with esteemed colleagues such as Sun Ae Kim and Soo Bin Park. These partnerships have contributed to his research advancements, further establishing his role as a leader in cancer research and innovation.

Conclusion

Si Young Song's contributions to cancer research through his innovative patents highlight the potential for groundbreaking treatments in the face of formidable diseases. His work not only paves the way for new therapeutic agents but also fosters hope for improved patient outcomes in the fight against pancreatic cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…